Jul 30, 2014 at 09:19 | Source: CNBC-TV18
Market expert Inderjeet Singh Bhatia of Macquarie Research believes it is too early in the cycle to go negative on quality stock like L&T. However, the brokerage house has cut its target price marginally by around 2 percent to Rs 1,922 while maintaining an outperforming rating on the stock.
Jul 18, 2014 at 12:05 | Source:
CLSA holds a contrarian view with a target price of Rs 2420. It still expects Bajaj to register a healthy 15 percent EPS CAGR over FY14-17 after a muted 2 percent CAGR over the last two years.
Jul 15, 2014 at 16:38 | Source:
CRISIL Ratings believes agrochemicals will be one of the fastest-growing industries in Indias manufacturing sector. "Expect the industry to post a compounded annual growth rate (CAGR) of 12% - 13% between fiscals 2014 and 2019", says the report.
Jul 11, 2014 at 15:46 | Source:
Emkay believes the chemical sector is expected to grow at a CAGR of 17% in next 5 years as exports have emerged as key growth driver with encouraging opportunities in domestic market.
Jul 07, 2014 at 19:30 | Source:
Religare Capital has come out with its report on cement sector. With construction activity gathering pace in the last 2 quarters, we see a sustained pick-up in volumes as the infra activity picks up in the economy
Jul 04, 2014 at 15:04 | Source:
Sharekhan has come out with its report on Lupin. It is expected to see stronger traction in the US business on the back of the key generic launches in recent months and a strong pipeline in the US generic business
Jul 04, 2014 at 10:12 | Source: CNBC-TV18
Should the government make the right noises on fiscal prudence, banking will the sector to bet on, says Tirthankar Patnaik of Religare Capital Markets.
Jul 03, 2014 at 18:15 | Source: PTI
The company had received the permission from market regulator Sebi in March 2013 for its proposed Rs 700-crore IPO but did not launch the same due to bad market conditions.
Jul 01, 2014 at 11:18 | Source: CNBC-TV18
Eyeing M&A opportunities aggressively, Lupin looks to expand in complex injectables space in the United States. The companys CFO S Ramesh expects complex injectables to contribute significantly in 3-4 years.
Jun 19, 2014 at 18:32 | Source:
Motilal Oswal has come out with its report on Tribhovandas Bhimji Zaveri (TBZ). The company is expected to post 41% PAT CAGR over FY14-17. RoE, which has declined from 43% to 13% in two years, is likely to expand to 23% by FY17, says the report.
Messages on Cagr »


Platinum Member


Amara Raja Batt  

to value of ABL. The present PE of 22 , ROC of more than 30 , past CAGR of more than 20%pa over past several years , the just completed capacity expansion , the management policy of sticking to it`s area of competence , consistent performance , consistent policy of 10% payouts , all these parameters

5.42 PM Jul 6th


Gold Member


Resurgere Mines  

RoCE was recorded at 100.2% and ICR at 32.8. Its sales recorded a three-year compound average growth rate of 81%, while the CAGR of profit after tax stood at 561.4% // URL:

5.02 PM Jul 6th

Black blades

Gold Member


NIIT Tech  

Nope! See Niit tech CAGR Growth rate... Some short term positives, that comes to my mind as of now: 1. Airport AAI Data management and upgradation Contract, For which expenses occurred heavily during FY14 but revenues will start flowing this year 2. Deal order wins consistent at the rate

5.13 PM Jul 5th


Gold Member


Arvind Remedies  

Post Budget Target 60 . There will be tax reduction in this sector to promote the product and Arvind Remedies will be a big gainer as their sales is moving 40% CAGR. Mr.Harsabardhan who is a doctor must be keen to promote the pharmaceutical sector.

4.13 PM Jul 4th


Gold Member


Arvind Remedies  

CAGR 40%. Similar stock is priced at 120. Accumulate to see multibagger in the near future with a small trigger let it be approved new sophisticated manufacturing facility or reduction of exercise duty to Ayurbedic medicine etc.

12.29 PM Jul 4th


Platinum Member


Shree Cements  

Best cement company in the sector...Just invest and forget for 8-10 yrs...Just try to buy 1 share a month like can give CAGR of 15-20% over long term. may be more... Regards,

3.44 PM Jul 3rd


Platinum Member


Ybrant Digital  

Hi ReddyM, will look into that and get back to you, Management`s comments has left room for both Topline and Bottom line expansion, COGS has improved sequentially,overall we should expect a 25 percentage CAGR for this FY on the top line with a more than pro-rata bottom line expansion. Their base

3.20 PM Jul 3rd

CCL Products  

company is going to grow 40% CAGR over next 3 years , the profits will triple in that effect , and so you can expect around 200 levels in 12-15 months

12.05 PM Jul 3rd


New Member



Ha ha since you guys are an encyclopedia on NMDC, I would ask you only one question. Why does the 10 year CAGR of NMDC revenue growth have 100% correlation with 10 year CAGR of International Iron Ore Price????

10.13 AM Jul 3rd


Platinum Member



Dear Krayji, I believe LT is gonna touch INR 3000/- in the next 8-12 quarters. Even on a long term basis one can expect a 25% CAGR for the next 4 years.

3.31 PM Jul 2nd

Explore Moneycontrol

Copyright © Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of is prohibited.